Pioneers of Precision Neurology
Neurgain is breaking new ground in the treatment of damage to the central nervous system and spinal cord. For years, patients and clinicians have dealt with the inconveniences of imprecise delivery of medications, including safety and efficacy concerns. With Neurgain’s strategies and delivery methods, therapeutics can be delivered with precision to the targeted location where they are needed.
Better Medicine Through Better Delivery.
We believe that the scientific community can best address disorders arising from damage to the central nervous system and spinal cord by innovating therapeutic strategies. With new methods to deliver therapeutics exactly where they are needed, we can move medicine forward together. This is Precision Neurology.
Neurgain’s technology is being used for its own flagship gene therapy for chronic spasticity and neuropathic pain. Neurgain also welcomes licensing partnerships with organizations that share its dedication to improving medication delivery for neural conditions.
Novel Subpial Vector Delivery
The development of subpial delivery allows for a new flexibility in how gene and cell therapies reach their target, whether for widespread transgene expression or segmented/site-specific expression
